Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

Famotidine Research Group

Résultat de rechercheexamen par les pairs

196 Citations (Scopus)
Langue d'origineEnglish
Pages (de-à)1129-1131.e3
JournalGastroenterology
Volume159
Numéro de publication3
DOI
Statut de publicationPublished - sept. 2020

Financement

Bailleurs de fondsNuméro du bailleur de fonds
Cold Spring Harbor
Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York
Columbia University Mailman School of Public Health, New York, New York
Department of Biostatistics
Division of Digestive and Liver Diseases
Division of Pulmonary, Allergy, and Critical Care Medicine
Cold Spring Harbor Laboratory
Department of Medicine, Georgetown University

    ASJC Scopus Subject Areas

    • Hepatology
    • Gastroenterology

    Citer

    Famotidine Research Group (2020). Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study. Gastroenterology, 159(3), 1129-1131.e3. https://doi.org/10.1053/j.gastro.2020.05.053